ASCO 2021: Presentations about whole genome sequencing

At the congress of the American Society of Clinical Oncology (ASCO) on 4-8 June 2021 researchers Kris Samsom and Luuk Schipper of the Dutch Cancer Institute (NKI) have presented their findings on whole genome sequencing.

In the poster presentation

Whole Genome Sequencing (WGS) is feasible in routine clinical care

Kris Samsom of the Dutch Cancer Institute explains the results of their research in which they conclude that WGS is feasible in routine diagnostics.

In the poster presentation

Whole Genome Sequencing (WGS) improves sarcoma diagnosis and patient care

Luuk Schipper of the Dutch Cancer Institute explains how they came to the conclusion in their research that WGS can help improve the diagnosis and the treatment of patients with sarcomas.

More information

You read an article in the category Scientific publications. You may also be interested in Whole genome sequencing.
All news

Also read

New CPoC grant awarded: GLOW – GLioblastoma targeted treatment Option maximisation by WGS

New CPoC grant awarded: GLOW – GLioblastoma targeted treatment Option maximisation by WGS

27-05-2021

Oncode Institute has announced that the 13th grant within the Clinical Proof of Concept programme has been awarded. Oncode Investigator …

Take a virtual tour of our laboratory: from the biopsy to the patient report

Take a virtual tour of our laboratory: from the biopsy to the patient report

26-01-2021

What happens to your tumor tissue and blood during a comprehensive DNA test? What exactly does all the complex equipment …

In the media: Rarity – Personalised cancer treatment – fact not fiction

In the media: Rarity – Personalised cancer treatment – fact not fiction

28-02-2022

Imagine a world in which each person’s cancer is treated with a personalised, targeted medical treatment regimen. A world in …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl